Lorazepam Tablet
Product Images NDC 71335-0329

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 71335-0329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713350329)

Label for Lorazepam 0.5 mg tablet, a Schedule IV controlled substance, packaged by Bryant Ranch Prepack in Burbank, CA. The label indicates the product is for oral use, with a package count of 30 tablets. It includes storage instructions at 20°-25°C (68°-77°F), a caution about drowsiness, and a comparison to Ativan 0.5 mg tablets by Leading Pharma LLC. The NDC is 71335-0329-1.*

FDA Label Image

Lorazepam Structure (Lorazepam Structure)

Chemical structure of Lorazepam, showing its molecular formula C15H10Cl2N2O2 and molecular weight of 321.16.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.